Back to FARALLON CAPITAL MANAGEMENT, L.L.C.

AVTX
1 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in AVALO THERAPEUTICS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 916,000 shares of AVTX (AVALO THERAPEUTICS INC), worth $13.7M as of 2026-Q1. This is a new position. AVTX represents 0.1% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$13.7M

Current Shares

916,000

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
916,000
-
$13.7M0.1%$18.85
39

Other major holders of AVTX: FMR LLC, Avoro Capital Advisors LLC, UBS Group AG, VANGUARD GROUP INC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used